[ITEM]
06.02.2020

Normal Mappr For Mac

29
Arch Ophthalmol. Author manuscript; available in PMC 2007 Aug 9.

Avoid the Mac-only Apple Partition Map (APM) scheme. Click the “Erase” button when you’re done and Disk Utility will format your disk with the settings you specified. This will erase all the files on the drive! You’re now done–be sure to eject the disk before you remove it from your Mac. A diffuse map can not always give you the depth of a material. Here (for example some kind of tiled checker kitchen floor) you wouldn't like to have one tile to be deeper than the other tiles. Therefor the height map has to be different. But of course, most of the time you can easily create a height map from a diffuse map with the proper tools.

Published in final edited form as:
doi: 10.1001/archopht.124.2.193
NIHMSID: NIHMS24622
The publisher's final edited version of this article is available at Arch Ophthalmol
See other articles in PMC that cite the published article.

Abstract

Objective

To report normal macular thickness measurements in healthy eyes using the latest commercially available optical coherence tomography (OCT) mapping software, version 3.0, from the Stratus OCT (OCT3).

Methods

Thirty-seven eyes from 37 healthy subjects underwent a complete ophthalmologic examination, including OCT. Six radial scans, 6 mm in length and centered on the fovea, were obtained using the OCT3. Retinal thickness was automatically calculated by OCT mapping software. Measurements were displayed as the mean and standard deviation for each of the 9 regions defined in the Early Treatment Diabetic Retinopathy Study.

Results

Foveal thickness (mean thickness in the central 1000-μm diameter area) and central foveal thickness (mean thickness at the point of intersection of 6 radial scans) on the OCT3 were 212 ± 20 and 182 ± 23 μm, respectively. Macular thickness measurements were thinnest at the center of the fovea, thickest within 3-mm diameter of the center, and diminished toward the periphery of the macula. The temporal quadrant was thinner than the nasal quadrant. Central foveal thickness was also manually determined as 170 ± 18 μm, approximately 12 μm less than the value automatically obtained from the OCT3 software. There was no correlation between age and foveal thickness (P = .80).

I can get the cursor to move around on the screen but nothing clicks. Yes I've tried everything, old drivers, delete, reinstall, etc Teh closest I got was having it work like a mouse and clicking.but now I can't even get that back. Wacom ptz 930 driver download. Straight from Wacom's mouth, Intuos 3 is no longer supported so unless someone has some sort of workaround, I need a new tablet so I can continue working.

Conclusions

Mean foveal thickness measurements were 38 to 62 μm thicker than previously reported values, while mean central foveal thickness measurements were 20 to 49 μm thicker than previously published values. This discrepancy should be considered when interpreting OCT scans.

INTRODUCTION

Macular edema is a common cause of visual loss. Abnormal fluid accumulation within the retina and a concomitant increase in retinal thickness usually result from the breakdown of the blood-retinal barrier. This process can be found in those with diabetic retinopathy, retinal vein occlusion, uveitis, and other ocular disorders. However, it has been observed repeatedly in clinical practice that the presence of macular edema does not necessarily preclude good vision., Nussenblatt et al were able to demonstrate that the degree of macular thickening, rather than the presence of macular edema, is significantly correlated with visual acuity. Traditional methods for evaluating macular edema, such as slitlamp biomicroscopy, stereoscopic photography, and fluorescein angiography, are relatively insensitive to small changes in retinal thickness and are qualitative at best. The introduction of optical coherence tomography (OCT) has enabled clinicians to reliably detect and measure small changes in macular thickness and to quantitatively evaluate the efficacy of different therapeutic modalities.

The latest OCT model (Stratus OCT [OCT3]; Carl Zeiss Meditec, Dublin, Calif) was made commercially available in 2002. It provides a 4-fold increase in imaging speed and better resolution (axial resolution, <10 μm) than earlier generations of the instrument. Based on our experience with the OCT3 and previous versions of the system, we observe that the macular thickness measurements for healthy eyes are higher than the values obtained using earlier versions of the instrument, including the prototype OCT. Recently, Frank et al compared macular thickness measurements from 2 versions of OCT scanners: OCT1 and OCT3. Scans were acquired from both eyes of 8 consecutive patients with suspected macular edema. The measurements from the 2 instruments were statistically different. Therefore, as the OCT3 becomes more widely available and used, normative data will be important in interpreting pathological features of the macula.

This study measures and defines normal macular thickness values in healthy eyes using OCT3 mapping software. To our knowledge, this is the first study to provide normative macular thickness data for the OCT3 system.

METHODS

The study protocol was approved and monitored by the Human Investigation Review Committee at New England Medical Center. All participants engaged in an informed consent process and signed a written consent document before study procedures were carried out. Healthy subjects were examined at New England Eye Center between August 1, 2003, and February 27, 2004. All subjects underwent a complete ophthalmologic examination, including a medical and family history, best-corrected visual acuity testing with Early Treatment Diabetic Retinopathy Study charts, Humphrey SITA standard 24-2 visual field testing, applanation tonometry, slitlamp biomicroscopy, indirect ophthalmoscopy, and color fundus photography. Optical coherence tomograms were acquired through a dilated pupil by an experienced operator using the OCT3 (Carl Zeiss Ophthalmic Systems, Inc, Humphrey Division, Dublin).

Exclusion criteria for healthy eyes included any history or evidence of pathological features of the retina, diabetes mellitus or other systemic disease that could affect the eye, glaucoma or first-degree relative with glaucoma, intraocular pressure higher than 21 mm Hg, abnormal visual fields, intraocular surgery or laser therapy (although refractive surgery >1 year before enrollment was acceptable), best-corrected visual acuity worse than 20/32, and refractive error greater than 6.00 or less than −6.0 diopters.

The macular thickness map scan protocol on the OCT3 was used to obtain 6 consecutive macular scans, 6 mm in length, centered on the fovea, at equally spaced angular orientations. The cross-sectional images were analyzed using OCT3 mapping software that used an edge detection technique to locate the strongest 2 edges in each tomogram, presumed to be at the vitreoretinal interface and the anterior surface of the retinal pigment epithelial–choriocapillaris region. Retinal thickness was measured as the distance between these 2 interfaces at each measurement point along the scan’s x-axis. Bilinear interpolation in polar coordinates was used to estimate the thickness of the wedges between each consecutive OCT scan.

We selected the retinal map analysis protocol on the OCT3 to reconstruct a surface map as a false-color topographic image displayed with numeric averages of the measurements for each of the 9 map sectors as defined by the Early Treatment Diabetic Retinopathy Study. The inner and outer rings were segmented into 4 quadrants, with radii of 1.5 and 3 mm, respectively. Foveal thickness was defined as the average thickness in the central 1000-μm diameter of the Early Treatment Diabetic Retinopathy Study layout (Figure 1A). Central foveal thickness was defined as the mean thickness at the point of intersection of the 6 radial scans (Figure 1B).

Foveal thickness (A) and central foveal thickness (B). In A, foveal thickness is defined as the mean thickness within the central 1000-μm diameter area (the central blue circle on the Early Treatment Diabetic Retinopathy Study map). In B, central foveal thickness is defined as the mean thickness measured at the point of intersection of the 6 radial scans on optical coherence tomography. The mean foveal thickness is approximately 30 μm greater than the mean central foveal thickness.

In addition, the OCT3 mapping software was used to manually locate the minimum value along each radial scan using the raw data. All 6 values were averaged to determine the mean central foveal thickness for each subject. The manually determined central foveal thickness measurements were compared with the values generated by the software, corresponding to the box labeled “Center” on the OCT3 patient printout.

The relationship between foveal thickness and age was investigated using linear regression analysis. Statistical analysis was performed with a commercially available software program (SPSS 11.0.1; SPSS Inc, Chicago, 1ll).

RESULTS

Thirty-seven healthy eyes from 37 healthy subjects were examined clinically and by the OCT3. The patients were aged 22 to 71 years (median, 43 years). There were 26 women (70%) and 11 men (30%). The mean and standard deviation retinal thickness by sector are shown in Figure 2 and Table 1. The foveal thickness never exceeded 252 μm in any of the healthy eyes. As expected, macular thickness was thinnest at the center, thickest within 3-mm diameter of the center, and diminished toward the periphery of the macula. The temporal quadrant was thinner than the nasal quadrant. The superior and nasal quadrants were thickest overall. In this study, the inner nasal sector was thickest in 29 patients (78%), the inner inferior sector was thickest in 6 patients (16%), the outer superior sector was thickest in 1 patient (3%), and the inner superior sector was thickest in 1 patient (3%).

Macular thickness measurements for a healthy eye population in this study, displayed as the mean and standard deviation in 9 regions, as defined in the Early Treatment Diabetic Retinopathy Study (A) and a false-color map for a prototypical healthy eye (B). I indicates inferior; N, nasal; S, superior; and T, temporal.

Table 1

Macular Thickness Measurements in 37 Healthy Eyes Using the OCT3

RegionRetinal Thickness in the Healthy Eves, Mean ± SD
Fovea (500-μm radius)212±20
Center
 Automatically determined182 ±23
 Manually determined170 ± 18
Inner ring (1.5-mm radius)
 Superior255 ± 17
 Inferior260 ±15
 Temporal251 ±13
 Nasal267 ± 16
Outer ring (3-mm radius)
 Superior239 ± 16
 Inferior210 ± 13
 Temporal210 ± 14
 Nasal246 ± 14

Abbreviation: OCT3, Straus optical coherence tomograph.

The standard deviation of the mean thickness of each sector outside the central 1000-μm diameter was consistently approximately 15 μm, demonstrating little variability in thickness measurements by OCT3. The SDs of 20 and 23 μm for mean foveal thickness and mean central foveal thickness, respectively, were slightly larger. The standard deviation of the 6 central macular measurements provided a simple estimate of the measurement reproducibility for a given patient. The average of this reproducibility was 11 μm. The mean ± SD central foveal thickness was manually measured as 170 ± 18 μm, approximately 12 μm less than the value automatically obtained from the OCT3 software.

Top 15 sfm installer for mac. Get a Bootcamp partition that allows you to run full Windows OS on your Mac. It's your best bet trust me, rather than whining and waiting for SFM to get ported to OSX that only god knows when. It will get SFM running normally like it should on a PC, but don't expect anything fancy with integrated graphics. SFM installer for Mac OS X was added by Gredwitch in Jan 2017 and the latest update was made in Nov 2017. The list of alternatives was updated Jan 2017. It's possible to update the information on SFM installer for Mac OS X or report it as discontinued, duplicated or spam. Note that it'll be also a bit harder to launch SFM on your Mac. Open Wine.app in your Applications folder. A tiny Wine icon should appear top right of the screen. Click on it and click on File Manager. A window should open. Click on the little letter called /. Another window will open with the path on it's top right, and this is the path you shall use. SFM installer for Mac OS X. This scripted application will install the famous animation software Source Filmmaker on your Mac. Most of the warning are displayed on the app. Free Personal Mac.

By using linear regression analysis, we found no relationship between age and foveal thickness within the central 1000-μm diameter (P = .80) (Figure 3).

Regression plot of foveal thickness vs age. There is no relationship between foveal thickness and age (P = .80).

A summary of previous studies that have measured retinal thickness in healthy eyes using OCT is shown in Table 2 for comparison with this study.

Table 2

Macular Thickness Measurements in Healthy Eyes Reported in Previous Studies Using OCT

SourceNo. of Eves StudiedType of OCT DeviceProtocol No. of ScansFoveal Thickness (1000-μm Diameter)*Central Foveal Thickness, μm*
Hee et al,8 199520Prototype6NS147 ± 17
Hee et al,9 199873Prototype6174 ± 18152 ± 21
Baumann et al,11 199818Prototype1NS154 ± 13
Otani et al,12 199910Commercial1NS133 ± 9
Schaudig et al,13 200025Commercial6NS152 ± 17
Konno et al,14 200124Commercial2NS155 ± 20
Neubauer et al,15 200121Commercial6NS154 ± 26
Massin et al,16 200260Commercial6170 ± 18146 ± 20
Kanai et al,17 200247NSNSNS142 ± 15
Sanchez-Tocino et al,18 200244Commercial6NS145 ± 16
Goebel and Kretzchmar-Gross,19 200230OCT24NS153 ± 15
Lattanzio et al,20 200250NS3NS162 ± 13
Paunescu et al,21 200410OCT36204 ± 20164 ± 21
Present study37OCT36212 ± 20182 ± 23

Abbreviations: NS, data not specified; OCT, optical coherence tomography.

COMMENT

Optical coherence tomography has emerged as a useful imaging technique by providing new high-resolution cross-sectional information about various pathological features of the macula. It allows clinicians to quantitatively measure retinal thickness in a reliable and highly reproducible manner.,,, , The introduction of the commercial OCT3 in 2002 provided faster imaging speed and better visualization of intraretinal morphological features compared with earlier versions of the instrument. Although there are several articles,, that report normative data for the prototype OCT, OCT1, and OCT2, to our knowledge, such data for OCT3 have been published in only 1 other article. That study had a sample size of 10 and characterized the reproducibility of OCT3 measurements.

Our results are different from previously published values obtained using earlier versions of the device. In our study, the mean ± SD foveal thickness (average thickness in the central 1000-μm diameter area) was 212 ± 20 μm, approximately 38 to 62 μm thicker than previously reported values. The mean ± SD central foveal thickness (average thickness at the point of intersection of 6 radial scans) was automatically determined to be 182 ± 23 μm, approximately 29 to 49 μm thicker than previously published values. Clinicians should be aware of these discrepancies when interpreting OCT images from different OCT models. These discrepancies may be a direct result of the greater resolution achieved by the more recent OCT systems. Less movement by the patient because of faster scanning times and more refined algorithms have allowed better image quality. We found that the thickness measurements in the 4 peripheral outer quadrants on the OCT3 were thinner than those reported in the literature. This may reflect the difference in scan length between the OCT3 and previous versions of the instrument. The OCT3 uses a scan length of 6 mm, whereas the OCT1, which was based on the prototype, used a scan length of 4.5 mm. As a result, the OCT3 scans more peripheral regions of the retina that are anatomically thinner. The 4 outermost zones measured by the OCT3 are thinnest, as expected from histological examination of the eye. In previous reports,, the superior and inferior quadrants were thickest, presumably from the superior and inferior arcuate bundling of the nerve fibers. Our findings show that the superior and nasal quadrants were thickest. We identified the nasal quadrant as the thickest region within the central 3-mm diameter. This is consistent with the anatomical relationship of the converging of nerve fibers with the optic disc.

Most of the OCT studies,,, in the literature report central foveal thickness only. Investigators have shown that central foveal thickness is significantly correlated with best-corrected visual acuity in healthy and diabetic eyes. However, foveal thickness may be more indicative of changes in the macula than central foveal thickness for several reasons. Foveal thickness is determined from many more data points than central foveal thickness. For example, each radial scan on the OCT3 is composed of a sequence of 512 A-scans. The macular thickness map scan protocol uses 6 radial scans per individual. Within the central 1000-μm diameter area, foveal thickness is determined from 512 data points, whereas central foveal thickness is determined from only 6 data points. In addition, we were able to manually measure the central foveal thickness from the raw data and compare this value with the computer output. We found the mean ± SD central foveal thickness to be 170 ± 18 μm, approximately 12 μm less than the value automatically obtained from the OCT3 software. This may reflect the difference in approach between the manual method and the automatic method of the OCT3 mapping software. The software automatically determined the mean and standard deviation thickness for the center point where all 6 scans intersected, whereas we manually located the minimum point on each separate radial scan and averaged those values. If the OCT scans were not perfectly centered on the patient’s fixation point for all 6 scans, the point of intersection would not correspond to the center exactly (Figure 4). This may give falsely elevated values. Given that the awake human eye is in constant motion, the minimum point for each radial scan will virtually never converge at the center, despite faster OCT3 scanning speeds. Because the central point is the smallest area of measurement, it will be most affected by tiny eye movements, followed by the central foveal zone. As a result, the standard deviation for central foveal thickness is the largest. Consequently, foveal thickness may be a more practical and reliable indicator than central foveal thickness for changes in the macula. We believe future OCT studies should report foveal thickness, in addition to central foveal thickness, in the evaluation of the efficacy of different therapies for macular edema.

The optical coherence tomographic (OCT) image (A), the fundus image (B), and the false-color map and numeric printout (C) for the right eye of a healthy patient who did not have well-aligned scans. In C, the central blue area corresponding to the fovea is off center superiorly. The OCT software determined the center (mean ± SD central foveal thickness) to be 207 ± 18 μm. Misaligned scans may give falsely elevated values. I indicates inferior; N, nasal; S, superior; and T, temporal.

Recently, Brown et al directly compared the clinical gold standard for the detection of macular edema (contact lens biomicroscopy) with the OCT3 for the detection of diabetic foveal edema. Because of the lack of normative data on the OCT3, the study suggested that the cutoff for the upper level of normal foveal thickness be 200 μm, based on their analysis of the existing literature. Our findings do not agree with their assessment. We use 2 SDs to define the cutoffs for the upper and lower levels of normal foveal thickness. Therefore, macular thickening can be suspected if foveal thickness is greater than 252 μm and macular thinning can be suspected if foveal thickness is less than 172 μm when measured with the OCT3. In the present study, the only 2 outliers were a young man who had a foveal thickness of 252 μm and a middle-aged woman who had a foveal thickness of 154 μm, both exceeding the normal value by more than 2 SDs. Such outlying values can occur and do arise in nearly all experimental data. Patients with subclinical macular thickening or thinning, and other risk factors, may require more frequent follow-up visits. Further OCT studies are needed to investigate whether diabetic patients with subclinical thickening are at higher risk for developing diabetic retinopathy.

Although it has been suspected that macular thickness might decline slightly with age, no statistically significant relationship could be found from this study. These findings are consistent with studies by Hee et al and Sanchez-Tocino et al. Our study also showed no significant difference in mean foveal thickness between men (204 μm; range, 154–232 μm) and women (207 μm; range, 173–252 μm). Future studies with larger sample sizes and a more even distribution of men and women may provide more useful information regarding differences by age, sex, and race.

In conclusion, normative values for macular thickness in a healthy population were obtained using commercially available OCT3 mapping software. Mean foveal thickness measurements were 38 to 62 μm thicker than previously reported values, while mean central foveal thickness measurements were 20 to 49 μm thicker than previously published values. This discrepancy should be considered when interpreting OCT scans.

Footnotes

Financial Disclosure: Drs Fugimoto and Schuman receive royalties from intellectual property licensed by the Massachusetts Institute of Technology to Carl Zeiss Meditec.

References

1. Meredith TA, Kenyon KR, Singerman LJ, Fine SL. Perifoveal vascular leakage and macular oedema after intracapsular cataract extraction. Br J Ophthalmol. 1976;60:765–769.[PMC free article] [PubMed] [Google Scholar]
2. Stark WJ, Maumenee AE, Fagadau W, et al. Cystoid macular edema in pseudophakia. Surv Ophthalmol. 1984;28:442–451. [PubMed] [Google Scholar]
3. Nussenblatt RB, Kaufman SC, Palestine AG, et al. Macular thickening and visual acuity: measurements in patients with cystoid macular edema. Ophthalmology. 1987;94:1134–1139. [PubMed] [Google Scholar]
4. Shahidi M, Ogura Y, Blair NP, et al. Retinal thickness analysis for quantitative assessment of diabetic macular edema. Arch Ophthalmol. 1991;109:1115–1119. [PubMed] [Google Scholar]
5. Huang D, Swanson EA, Lin CP, et al. Optical coherence tomography. Science. 1991;254:1178–1181.[PMC free article] [PubMed] [Google Scholar]
6. Hee MR, Izatt JA, Swanson EA, et al. Optical coherence tomography of the human retina. Arch Ophthalmol. 1995;113:325–332. [PubMed] [Google Scholar]
7. Puliafito CA, Hee MR, Lin CP, et al. Imaging of macular diseases with optical coherence tomography. Ophthalmology. 1995;102:217–229. [PubMed] [Google Scholar]
8. Hee MR, Puliafito CA, Wong C, et al. Quantitative assessment of macular edema with optical coherence tomography. Arch Ophthalmol. 1995;113:1019–1029. [PubMed] [Google Scholar]
9. Hee MR, Puliafito CA, Duker JS, et al. Topography of macular edema with optical coherence tomography. Ophthalmology. 1998;105:360–370.[PMC free article] [PubMed] [Google Scholar]
10. Massin P, Vicaut E, Haouchine B, et al. Reproducibility of retinal thickness measurements in healthy and diabetic eyes using optical coherence tomography. Arch Ophthalmol. 2001;119:1135–1142. [PubMed] [Google Scholar]
11. Baumann M, Gentile RC, Liebmann JM, Ritch R. Reproducibility of retinal thickness measurements in normal eyes using optical coherence tomography. Ophthalmic Surg Lasers. 1998;29:280–285. [PubMed] [Google Scholar]
12. Otani T, Kishi S, Maruyama Y. Patterns of diabetic macular edema with optical coherence tomography. Am J Ophthalmol. 1999;127:688–693. [PubMed] [Google Scholar]
13. Schaudig UH, Glaefke C, Scholz F, Richard G. Optical coherence tomography for retinal thickness measurement in diabetic patients without clinically significant macular edema. Ophthalmic Surg Lasers. 2000;31:182–186. [PubMed] [Google Scholar]
14. Konno S, Akiba J, Yoshida A. Retinal thickness measurements with optical coherence tomography and the retinal thickness analyzer. Retina. 2001;21:57–61. [PubMed] [Google Scholar]
15. Neubauer AS, Priglinger S, Ullrich S, et al. Comparison of foveal thickness measured with the retinal thickness analyzer and optical coherence tomography. Retina. 2001;21:596–601. [PubMed] [Google Scholar]
16. Massin P, Erginay A, Haouchine B, Mehidi AB, Paques M, Gaudric A. Retinal thickness in healthy and diabetic subjects measured using optical coherence tomography mapping software. Eur J Ophthalmol. 2002;12:102–108. [PubMed] [Google Scholar]
17. Kanai K, Abe T, Murayama K, Yoneya S. Retinal thickness and changes with age. Nippon Ganka Gakkai Zasshi. 2002;106:162–165. in Japanese. [PubMed] [Google Scholar]
18. Sanchez-Tocino H, Alvarez-Vidal A, Maldolnado MJ, et al. Retinal thickness study with optical coherence tomography in patients with diabetes. Invest Ophthalmol Vis Sci. 2002;43:1588–1594. [PubMed] [Google Scholar]
19. Goebel W, Kretzchmar-Gross T. Retinal thickness in diabetic retinopathy: a study using optical coherence tomography (OCT) Retina. 2002;22:759–767. [PubMed] [Google Scholar]
20. Lattanzio R, Brancato R, Pierro L, et al. Macular thickness measured by optical coherence tomography (OCT) in diabetic patients. Eur J Ophthalmol. 2002;12:482–487. [PubMed] [Google Scholar]
21. Paunescu LA, Schuman JS, Price LL, et al. Reproducibility of nerve fiber thickness, macular thickness, and optic nerve head measurements using Stratus OCT. Invest Ophthalmol Vis Sci. 2004;45:1716–1724.[PMC free article] [PubMed] [Google Scholar]
22. Jaffe GJ, Caprioli J. Optical coherence tomography to detect and manage retinal disease and glaucoma. Am J Ophthalmol. 2004;137:156–169. [PubMed] [Google Scholar]
23. Frank RN, Schulz L, Ave K, Iezzi R. Temporal variation in diabetic macular edema measured by optical coherence tomography. Ophthalmology. 2004;111:211–217. [PubMed] [Google Scholar]
24. Early Treatment Diabetic Retinopathy Study Research Group. ETDRS report number 7: Early Treatment Diabetic Retinopathy Study design and baseline patient characteristics. Ophthalmology. 1991;98:741–756. [PubMed] [Google Scholar]
25. Koozekanani D, Roberts C, Katz SE, Herderick EE. Intersession repeatability of macular thickness measurements with the Humphrey 2000 OCT. Invest Ophthalmol Vis Sci. 2000;41:1486–1491. [PubMed] [Google Scholar]
26. Muscat S, Parks S, Kemp E, Keating D. Repeatability and reproducibility of macular thickness measurements with the Humphrey OCT system. Invest Ophthalmol Vis Sci. 2002;43:490–495. [PubMed] [Google Scholar]
27. Brown JC, Solomon SD, Bressler SB, et al. Detection of diabetic foveal edema. Arch Ophthalmol. 2004;122:330–335. [PubMed] [Google Scholar]
[/ITEM]
[/MAIN]
06.02.2020

Normal Mappr For Mac

75
Arch Ophthalmol. Author manuscript; available in PMC 2007 Aug 9.

Avoid the Mac-only Apple Partition Map (APM) scheme. Click the “Erase” button when you’re done and Disk Utility will format your disk with the settings you specified. This will erase all the files on the drive! You’re now done–be sure to eject the disk before you remove it from your Mac. A diffuse map can not always give you the depth of a material. Here (for example some kind of tiled checker kitchen floor) you wouldn't like to have one tile to be deeper than the other tiles. Therefor the height map has to be different. But of course, most of the time you can easily create a height map from a diffuse map with the proper tools.

Published in final edited form as:
doi: 10.1001/archopht.124.2.193
NIHMSID: NIHMS24622
The publisher's final edited version of this article is available at Arch Ophthalmol
See other articles in PMC that cite the published article.

Abstract

Objective

To report normal macular thickness measurements in healthy eyes using the latest commercially available optical coherence tomography (OCT) mapping software, version 3.0, from the Stratus OCT (OCT3).

Methods

Thirty-seven eyes from 37 healthy subjects underwent a complete ophthalmologic examination, including OCT. Six radial scans, 6 mm in length and centered on the fovea, were obtained using the OCT3. Retinal thickness was automatically calculated by OCT mapping software. Measurements were displayed as the mean and standard deviation for each of the 9 regions defined in the Early Treatment Diabetic Retinopathy Study.

Results

Foveal thickness (mean thickness in the central 1000-μm diameter area) and central foveal thickness (mean thickness at the point of intersection of 6 radial scans) on the OCT3 were 212 ± 20 and 182 ± 23 μm, respectively. Macular thickness measurements were thinnest at the center of the fovea, thickest within 3-mm diameter of the center, and diminished toward the periphery of the macula. The temporal quadrant was thinner than the nasal quadrant. Central foveal thickness was also manually determined as 170 ± 18 μm, approximately 12 μm less than the value automatically obtained from the OCT3 software. There was no correlation between age and foveal thickness (P = .80).

I can get the cursor to move around on the screen but nothing clicks. Yes I've tried everything, old drivers, delete, reinstall, etc Teh closest I got was having it work like a mouse and clicking.but now I can't even get that back. Wacom ptz 930 driver download. Straight from Wacom's mouth, Intuos 3 is no longer supported so unless someone has some sort of workaround, I need a new tablet so I can continue working.

Conclusions

Mean foveal thickness measurements were 38 to 62 μm thicker than previously reported values, while mean central foveal thickness measurements were 20 to 49 μm thicker than previously published values. This discrepancy should be considered when interpreting OCT scans.

INTRODUCTION

Macular edema is a common cause of visual loss. Abnormal fluid accumulation within the retina and a concomitant increase in retinal thickness usually result from the breakdown of the blood-retinal barrier. This process can be found in those with diabetic retinopathy, retinal vein occlusion, uveitis, and other ocular disorders. However, it has been observed repeatedly in clinical practice that the presence of macular edema does not necessarily preclude good vision., Nussenblatt et al were able to demonstrate that the degree of macular thickening, rather than the presence of macular edema, is significantly correlated with visual acuity. Traditional methods for evaluating macular edema, such as slitlamp biomicroscopy, stereoscopic photography, and fluorescein angiography, are relatively insensitive to small changes in retinal thickness and are qualitative at best. The introduction of optical coherence tomography (OCT) has enabled clinicians to reliably detect and measure small changes in macular thickness and to quantitatively evaluate the efficacy of different therapeutic modalities.

The latest OCT model (Stratus OCT [OCT3]; Carl Zeiss Meditec, Dublin, Calif) was made commercially available in 2002. It provides a 4-fold increase in imaging speed and better resolution (axial resolution, <10 μm) than earlier generations of the instrument. Based on our experience with the OCT3 and previous versions of the system, we observe that the macular thickness measurements for healthy eyes are higher than the values obtained using earlier versions of the instrument, including the prototype OCT. Recently, Frank et al compared macular thickness measurements from 2 versions of OCT scanners: OCT1 and OCT3. Scans were acquired from both eyes of 8 consecutive patients with suspected macular edema. The measurements from the 2 instruments were statistically different. Therefore, as the OCT3 becomes more widely available and used, normative data will be important in interpreting pathological features of the macula.

This study measures and defines normal macular thickness values in healthy eyes using OCT3 mapping software. To our knowledge, this is the first study to provide normative macular thickness data for the OCT3 system.

METHODS

The study protocol was approved and monitored by the Human Investigation Review Committee at New England Medical Center. All participants engaged in an informed consent process and signed a written consent document before study procedures were carried out. Healthy subjects were examined at New England Eye Center between August 1, 2003, and February 27, 2004. All subjects underwent a complete ophthalmologic examination, including a medical and family history, best-corrected visual acuity testing with Early Treatment Diabetic Retinopathy Study charts, Humphrey SITA standard 24-2 visual field testing, applanation tonometry, slitlamp biomicroscopy, indirect ophthalmoscopy, and color fundus photography. Optical coherence tomograms were acquired through a dilated pupil by an experienced operator using the OCT3 (Carl Zeiss Ophthalmic Systems, Inc, Humphrey Division, Dublin).

Exclusion criteria for healthy eyes included any history or evidence of pathological features of the retina, diabetes mellitus or other systemic disease that could affect the eye, glaucoma or first-degree relative with glaucoma, intraocular pressure higher than 21 mm Hg, abnormal visual fields, intraocular surgery or laser therapy (although refractive surgery >1 year before enrollment was acceptable), best-corrected visual acuity worse than 20/32, and refractive error greater than 6.00 or less than −6.0 diopters.

The macular thickness map scan protocol on the OCT3 was used to obtain 6 consecutive macular scans, 6 mm in length, centered on the fovea, at equally spaced angular orientations. The cross-sectional images were analyzed using OCT3 mapping software that used an edge detection technique to locate the strongest 2 edges in each tomogram, presumed to be at the vitreoretinal interface and the anterior surface of the retinal pigment epithelial–choriocapillaris region. Retinal thickness was measured as the distance between these 2 interfaces at each measurement point along the scan’s x-axis. Bilinear interpolation in polar coordinates was used to estimate the thickness of the wedges between each consecutive OCT scan.

We selected the retinal map analysis protocol on the OCT3 to reconstruct a surface map as a false-color topographic image displayed with numeric averages of the measurements for each of the 9 map sectors as defined by the Early Treatment Diabetic Retinopathy Study. The inner and outer rings were segmented into 4 quadrants, with radii of 1.5 and 3 mm, respectively. Foveal thickness was defined as the average thickness in the central 1000-μm diameter of the Early Treatment Diabetic Retinopathy Study layout (Figure 1A). Central foveal thickness was defined as the mean thickness at the point of intersection of the 6 radial scans (Figure 1B).

Foveal thickness (A) and central foveal thickness (B). In A, foveal thickness is defined as the mean thickness within the central 1000-μm diameter area (the central blue circle on the Early Treatment Diabetic Retinopathy Study map). In B, central foveal thickness is defined as the mean thickness measured at the point of intersection of the 6 radial scans on optical coherence tomography. The mean foveal thickness is approximately 30 μm greater than the mean central foveal thickness.

In addition, the OCT3 mapping software was used to manually locate the minimum value along each radial scan using the raw data. All 6 values were averaged to determine the mean central foveal thickness for each subject. The manually determined central foveal thickness measurements were compared with the values generated by the software, corresponding to the box labeled “Center” on the OCT3 patient printout.

The relationship between foveal thickness and age was investigated using linear regression analysis. Statistical analysis was performed with a commercially available software program (SPSS 11.0.1; SPSS Inc, Chicago, 1ll).

RESULTS

Thirty-seven healthy eyes from 37 healthy subjects were examined clinically and by the OCT3. The patients were aged 22 to 71 years (median, 43 years). There were 26 women (70%) and 11 men (30%). The mean and standard deviation retinal thickness by sector are shown in Figure 2 and Table 1. The foveal thickness never exceeded 252 μm in any of the healthy eyes. As expected, macular thickness was thinnest at the center, thickest within 3-mm diameter of the center, and diminished toward the periphery of the macula. The temporal quadrant was thinner than the nasal quadrant. The superior and nasal quadrants were thickest overall. In this study, the inner nasal sector was thickest in 29 patients (78%), the inner inferior sector was thickest in 6 patients (16%), the outer superior sector was thickest in 1 patient (3%), and the inner superior sector was thickest in 1 patient (3%).

Macular thickness measurements for a healthy eye population in this study, displayed as the mean and standard deviation in 9 regions, as defined in the Early Treatment Diabetic Retinopathy Study (A) and a false-color map for a prototypical healthy eye (B). I indicates inferior; N, nasal; S, superior; and T, temporal.

Table 1

Macular Thickness Measurements in 37 Healthy Eyes Using the OCT3

RegionRetinal Thickness in the Healthy Eves, Mean ± SD
Fovea (500-μm radius)212±20
Center
 Automatically determined182 ±23
 Manually determined170 ± 18
Inner ring (1.5-mm radius)
 Superior255 ± 17
 Inferior260 ±15
 Temporal251 ±13
 Nasal267 ± 16
Outer ring (3-mm radius)
 Superior239 ± 16
 Inferior210 ± 13
 Temporal210 ± 14
 Nasal246 ± 14

Abbreviation: OCT3, Straus optical coherence tomograph.

The standard deviation of the mean thickness of each sector outside the central 1000-μm diameter was consistently approximately 15 μm, demonstrating little variability in thickness measurements by OCT3. The SDs of 20 and 23 μm for mean foveal thickness and mean central foveal thickness, respectively, were slightly larger. The standard deviation of the 6 central macular measurements provided a simple estimate of the measurement reproducibility for a given patient. The average of this reproducibility was 11 μm. The mean ± SD central foveal thickness was manually measured as 170 ± 18 μm, approximately 12 μm less than the value automatically obtained from the OCT3 software.

Top 15 sfm installer for mac. Get a Bootcamp partition that allows you to run full Windows OS on your Mac. It's your best bet trust me, rather than whining and waiting for SFM to get ported to OSX that only god knows when. It will get SFM running normally like it should on a PC, but don't expect anything fancy with integrated graphics. SFM installer for Mac OS X was added by Gredwitch in Jan 2017 and the latest update was made in Nov 2017. The list of alternatives was updated Jan 2017. It's possible to update the information on SFM installer for Mac OS X or report it as discontinued, duplicated or spam. Note that it'll be also a bit harder to launch SFM on your Mac. Open Wine.app in your Applications folder. A tiny Wine icon should appear top right of the screen. Click on it and click on File Manager. A window should open. Click on the little letter called /. Another window will open with the path on it's top right, and this is the path you shall use. SFM installer for Mac OS X. This scripted application will install the famous animation software Source Filmmaker on your Mac. Most of the warning are displayed on the app. Free Personal Mac.

By using linear regression analysis, we found no relationship between age and foveal thickness within the central 1000-μm diameter (P = .80) (Figure 3).

Regression plot of foveal thickness vs age. There is no relationship between foveal thickness and age (P = .80).

A summary of previous studies that have measured retinal thickness in healthy eyes using OCT is shown in Table 2 for comparison with this study.

Table 2

Macular Thickness Measurements in Healthy Eyes Reported in Previous Studies Using OCT

SourceNo. of Eves StudiedType of OCT DeviceProtocol No. of ScansFoveal Thickness (1000-μm Diameter)*Central Foveal Thickness, μm*
Hee et al,8 199520Prototype6NS147 ± 17
Hee et al,9 199873Prototype6174 ± 18152 ± 21
Baumann et al,11 199818Prototype1NS154 ± 13
Otani et al,12 199910Commercial1NS133 ± 9
Schaudig et al,13 200025Commercial6NS152 ± 17
Konno et al,14 200124Commercial2NS155 ± 20
Neubauer et al,15 200121Commercial6NS154 ± 26
Massin et al,16 200260Commercial6170 ± 18146 ± 20
Kanai et al,17 200247NSNSNS142 ± 15
Sanchez-Tocino et al,18 200244Commercial6NS145 ± 16
Goebel and Kretzchmar-Gross,19 200230OCT24NS153 ± 15
Lattanzio et al,20 200250NS3NS162 ± 13
Paunescu et al,21 200410OCT36204 ± 20164 ± 21
Present study37OCT36212 ± 20182 ± 23

Abbreviations: NS, data not specified; OCT, optical coherence tomography.

COMMENT

Optical coherence tomography has emerged as a useful imaging technique by providing new high-resolution cross-sectional information about various pathological features of the macula. It allows clinicians to quantitatively measure retinal thickness in a reliable and highly reproducible manner.,,, , The introduction of the commercial OCT3 in 2002 provided faster imaging speed and better visualization of intraretinal morphological features compared with earlier versions of the instrument. Although there are several articles,, that report normative data for the prototype OCT, OCT1, and OCT2, to our knowledge, such data for OCT3 have been published in only 1 other article. That study had a sample size of 10 and characterized the reproducibility of OCT3 measurements.

Our results are different from previously published values obtained using earlier versions of the device. In our study, the mean ± SD foveal thickness (average thickness in the central 1000-μm diameter area) was 212 ± 20 μm, approximately 38 to 62 μm thicker than previously reported values. The mean ± SD central foveal thickness (average thickness at the point of intersection of 6 radial scans) was automatically determined to be 182 ± 23 μm, approximately 29 to 49 μm thicker than previously published values. Clinicians should be aware of these discrepancies when interpreting OCT images from different OCT models. These discrepancies may be a direct result of the greater resolution achieved by the more recent OCT systems. Less movement by the patient because of faster scanning times and more refined algorithms have allowed better image quality. We found that the thickness measurements in the 4 peripheral outer quadrants on the OCT3 were thinner than those reported in the literature. This may reflect the difference in scan length between the OCT3 and previous versions of the instrument. The OCT3 uses a scan length of 6 mm, whereas the OCT1, which was based on the prototype, used a scan length of 4.5 mm. As a result, the OCT3 scans more peripheral regions of the retina that are anatomically thinner. The 4 outermost zones measured by the OCT3 are thinnest, as expected from histological examination of the eye. In previous reports,, the superior and inferior quadrants were thickest, presumably from the superior and inferior arcuate bundling of the nerve fibers. Our findings show that the superior and nasal quadrants were thickest. We identified the nasal quadrant as the thickest region within the central 3-mm diameter. This is consistent with the anatomical relationship of the converging of nerve fibers with the optic disc.

Most of the OCT studies,,, in the literature report central foveal thickness only. Investigators have shown that central foveal thickness is significantly correlated with best-corrected visual acuity in healthy and diabetic eyes. However, foveal thickness may be more indicative of changes in the macula than central foveal thickness for several reasons. Foveal thickness is determined from many more data points than central foveal thickness. For example, each radial scan on the OCT3 is composed of a sequence of 512 A-scans. The macular thickness map scan protocol uses 6 radial scans per individual. Within the central 1000-μm diameter area, foveal thickness is determined from 512 data points, whereas central foveal thickness is determined from only 6 data points. In addition, we were able to manually measure the central foveal thickness from the raw data and compare this value with the computer output. We found the mean ± SD central foveal thickness to be 170 ± 18 μm, approximately 12 μm less than the value automatically obtained from the OCT3 software. This may reflect the difference in approach between the manual method and the automatic method of the OCT3 mapping software. The software automatically determined the mean and standard deviation thickness for the center point where all 6 scans intersected, whereas we manually located the minimum point on each separate radial scan and averaged those values. If the OCT scans were not perfectly centered on the patient’s fixation point for all 6 scans, the point of intersection would not correspond to the center exactly (Figure 4). This may give falsely elevated values. Given that the awake human eye is in constant motion, the minimum point for each radial scan will virtually never converge at the center, despite faster OCT3 scanning speeds. Because the central point is the smallest area of measurement, it will be most affected by tiny eye movements, followed by the central foveal zone. As a result, the standard deviation for central foveal thickness is the largest. Consequently, foveal thickness may be a more practical and reliable indicator than central foveal thickness for changes in the macula. We believe future OCT studies should report foveal thickness, in addition to central foveal thickness, in the evaluation of the efficacy of different therapies for macular edema.

The optical coherence tomographic (OCT) image (A), the fundus image (B), and the false-color map and numeric printout (C) for the right eye of a healthy patient who did not have well-aligned scans. In C, the central blue area corresponding to the fovea is off center superiorly. The OCT software determined the center (mean ± SD central foveal thickness) to be 207 ± 18 μm. Misaligned scans may give falsely elevated values. I indicates inferior; N, nasal; S, superior; and T, temporal.

Recently, Brown et al directly compared the clinical gold standard for the detection of macular edema (contact lens biomicroscopy) with the OCT3 for the detection of diabetic foveal edema. Because of the lack of normative data on the OCT3, the study suggested that the cutoff for the upper level of normal foveal thickness be 200 μm, based on their analysis of the existing literature. Our findings do not agree with their assessment. We use 2 SDs to define the cutoffs for the upper and lower levels of normal foveal thickness. Therefore, macular thickening can be suspected if foveal thickness is greater than 252 μm and macular thinning can be suspected if foveal thickness is less than 172 μm when measured with the OCT3. In the present study, the only 2 outliers were a young man who had a foveal thickness of 252 μm and a middle-aged woman who had a foveal thickness of 154 μm, both exceeding the normal value by more than 2 SDs. Such outlying values can occur and do arise in nearly all experimental data. Patients with subclinical macular thickening or thinning, and other risk factors, may require more frequent follow-up visits. Further OCT studies are needed to investigate whether diabetic patients with subclinical thickening are at higher risk for developing diabetic retinopathy.

Although it has been suspected that macular thickness might decline slightly with age, no statistically significant relationship could be found from this study. These findings are consistent with studies by Hee et al and Sanchez-Tocino et al. Our study also showed no significant difference in mean foveal thickness between men (204 μm; range, 154–232 μm) and women (207 μm; range, 173–252 μm). Future studies with larger sample sizes and a more even distribution of men and women may provide more useful information regarding differences by age, sex, and race.

In conclusion, normative values for macular thickness in a healthy population were obtained using commercially available OCT3 mapping software. Mean foveal thickness measurements were 38 to 62 μm thicker than previously reported values, while mean central foveal thickness measurements were 20 to 49 μm thicker than previously published values. This discrepancy should be considered when interpreting OCT scans.

Footnotes

Financial Disclosure: Drs Fugimoto and Schuman receive royalties from intellectual property licensed by the Massachusetts Institute of Technology to Carl Zeiss Meditec.

References

1. Meredith TA, Kenyon KR, Singerman LJ, Fine SL. Perifoveal vascular leakage and macular oedema after intracapsular cataract extraction. Br J Ophthalmol. 1976;60:765–769.[PMC free article] [PubMed] [Google Scholar]
2. Stark WJ, Maumenee AE, Fagadau W, et al. Cystoid macular edema in pseudophakia. Surv Ophthalmol. 1984;28:442–451. [PubMed] [Google Scholar]
3. Nussenblatt RB, Kaufman SC, Palestine AG, et al. Macular thickening and visual acuity: measurements in patients with cystoid macular edema. Ophthalmology. 1987;94:1134–1139. [PubMed] [Google Scholar]
4. Shahidi M, Ogura Y, Blair NP, et al. Retinal thickness analysis for quantitative assessment of diabetic macular edema. Arch Ophthalmol. 1991;109:1115–1119. [PubMed] [Google Scholar]
5. Huang D, Swanson EA, Lin CP, et al. Optical coherence tomography. Science. 1991;254:1178–1181.[PMC free article] [PubMed] [Google Scholar]
6. Hee MR, Izatt JA, Swanson EA, et al. Optical coherence tomography of the human retina. Arch Ophthalmol. 1995;113:325–332. [PubMed] [Google Scholar]
7. Puliafito CA, Hee MR, Lin CP, et al. Imaging of macular diseases with optical coherence tomography. Ophthalmology. 1995;102:217–229. [PubMed] [Google Scholar]
8. Hee MR, Puliafito CA, Wong C, et al. Quantitative assessment of macular edema with optical coherence tomography. Arch Ophthalmol. 1995;113:1019–1029. [PubMed] [Google Scholar]
9. Hee MR, Puliafito CA, Duker JS, et al. Topography of macular edema with optical coherence tomography. Ophthalmology. 1998;105:360–370.[PMC free article] [PubMed] [Google Scholar]
10. Massin P, Vicaut E, Haouchine B, et al. Reproducibility of retinal thickness measurements in healthy and diabetic eyes using optical coherence tomography. Arch Ophthalmol. 2001;119:1135–1142. [PubMed] [Google Scholar]
11. Baumann M, Gentile RC, Liebmann JM, Ritch R. Reproducibility of retinal thickness measurements in normal eyes using optical coherence tomography. Ophthalmic Surg Lasers. 1998;29:280–285. [PubMed] [Google Scholar]
12. Otani T, Kishi S, Maruyama Y. Patterns of diabetic macular edema with optical coherence tomography. Am J Ophthalmol. 1999;127:688–693. [PubMed] [Google Scholar]
13. Schaudig UH, Glaefke C, Scholz F, Richard G. Optical coherence tomography for retinal thickness measurement in diabetic patients without clinically significant macular edema. Ophthalmic Surg Lasers. 2000;31:182–186. [PubMed] [Google Scholar]
14. Konno S, Akiba J, Yoshida A. Retinal thickness measurements with optical coherence tomography and the retinal thickness analyzer. Retina. 2001;21:57–61. [PubMed] [Google Scholar]
15. Neubauer AS, Priglinger S, Ullrich S, et al. Comparison of foveal thickness measured with the retinal thickness analyzer and optical coherence tomography. Retina. 2001;21:596–601. [PubMed] [Google Scholar]
16. Massin P, Erginay A, Haouchine B, Mehidi AB, Paques M, Gaudric A. Retinal thickness in healthy and diabetic subjects measured using optical coherence tomography mapping software. Eur J Ophthalmol. 2002;12:102–108. [PubMed] [Google Scholar]
17. Kanai K, Abe T, Murayama K, Yoneya S. Retinal thickness and changes with age. Nippon Ganka Gakkai Zasshi. 2002;106:162–165. in Japanese. [PubMed] [Google Scholar]
18. Sanchez-Tocino H, Alvarez-Vidal A, Maldolnado MJ, et al. Retinal thickness study with optical coherence tomography in patients with diabetes. Invest Ophthalmol Vis Sci. 2002;43:1588–1594. [PubMed] [Google Scholar]
19. Goebel W, Kretzchmar-Gross T. Retinal thickness in diabetic retinopathy: a study using optical coherence tomography (OCT) Retina. 2002;22:759–767. [PubMed] [Google Scholar]
20. Lattanzio R, Brancato R, Pierro L, et al. Macular thickness measured by optical coherence tomography (OCT) in diabetic patients. Eur J Ophthalmol. 2002;12:482–487. [PubMed] [Google Scholar]
21. Paunescu LA, Schuman JS, Price LL, et al. Reproducibility of nerve fiber thickness, macular thickness, and optic nerve head measurements using Stratus OCT. Invest Ophthalmol Vis Sci. 2004;45:1716–1724.[PMC free article] [PubMed] [Google Scholar]
22. Jaffe GJ, Caprioli J. Optical coherence tomography to detect and manage retinal disease and glaucoma. Am J Ophthalmol. 2004;137:156–169. [PubMed] [Google Scholar]
23. Frank RN, Schulz L, Ave K, Iezzi R. Temporal variation in diabetic macular edema measured by optical coherence tomography. Ophthalmology. 2004;111:211–217. [PubMed] [Google Scholar]
24. Early Treatment Diabetic Retinopathy Study Research Group. ETDRS report number 7: Early Treatment Diabetic Retinopathy Study design and baseline patient characteristics. Ophthalmology. 1991;98:741–756. [PubMed] [Google Scholar]
25. Koozekanani D, Roberts C, Katz SE, Herderick EE. Intersession repeatability of macular thickness measurements with the Humphrey 2000 OCT. Invest Ophthalmol Vis Sci. 2000;41:1486–1491. [PubMed] [Google Scholar]
26. Muscat S, Parks S, Kemp E, Keating D. Repeatability and reproducibility of macular thickness measurements with the Humphrey OCT system. Invest Ophthalmol Vis Sci. 2002;43:490–495. [PubMed] [Google Scholar]
27. Brown JC, Solomon SD, Bressler SB, et al. Detection of diabetic foveal edema. Arch Ophthalmol. 2004;122:330–335. [PubMed] [Google Scholar]